Cargando…

Efficacy evaluation of contrast-enhanced magnetic resonance imaging in differentiating glioma from metastatic tumor of the brain and exploration of its association with patients’ neurological function

OBJECTIVE: To determine the efficacy of contrast-enhanced MRI in differentiating glioma (GL) from the metastatic tumor of the brain (MTB) and its association with patients’ neurological function. METHODS: A retrospective analysis was conducted on 49 cases of pathologically confirmed GL and 42 cases...

Descripción completa

Detalles Bibliográficos
Autores principales: Shi, Zhuo, Jiang, Jiuming, Xie, Lizhi, Zhao, Xinming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9486092/
https://www.ncbi.nlm.nih.gov/pubmed/36147544
http://dx.doi.org/10.3389/fnbeh.2022.957795
_version_ 1784792201541189632
author Shi, Zhuo
Jiang, Jiuming
Xie, Lizhi
Zhao, Xinming
author_facet Shi, Zhuo
Jiang, Jiuming
Xie, Lizhi
Zhao, Xinming
author_sort Shi, Zhuo
collection PubMed
description OBJECTIVE: To determine the efficacy of contrast-enhanced MRI in differentiating glioma (GL) from the metastatic tumor of the brain (MTB) and its association with patients’ neurological function. METHODS: A retrospective analysis was conducted on 49 cases of pathologically confirmed GL and 42 cases of MTB admitted between April 2019 and January 2022. All patients were examined by a set of MRI sequences that included T1WI, T2WI, FLAIR, and DWI. The values of fractional anisotropy (FA), apparent diffusion coefficient (ADC), and operation coefficient (K(trans)) were calculated by taking the tumor parenchyma area, cystic area, and peritumor edema area as the regions of interest (ROIs). And according to the Mini-mental state examination (MMSE) results, the contrast-enhanced MRI with patients’ neurological dysfunction was observed. RESULTS: The clinical symptoms and MRI findings of MTB and GL were basically the same, mainly showing neurological symptoms. The tumor parenchyma area and cystic area were mainly located in the tumor periphery and tumor central area, respectively, while the peritumor edema area was widely distributed, showing an irregular patchy edema zone. Contrast-enhanced scans suggested an obvious enhancement in the tumor parenchymal area, presenting with nodular and annular enhancement, but no enhancement in the tumor cystic and peritumor edema areas. There was no difference between GL and MTB in FA values of tumor cystic area and peritumor edema area (P > 0.05), but the FA value of the parenchyma area of GL was higher (P < 0.05). Besides, GL and MTB showed no difference in ADC and K(trans) values (P > 0.05), while the former presented lower ADC values and higher K(trans) values of the peritumor edema area than the latter (P < 0.05). In patients with GL and MTB, the FA and K(trans) values of all ROIs in those with neurological dysfunction were higher compared with those without neurological dysfunction, while the ADC values were lower (P < 0.05). CONCLUSION: Contrast-enhanced MRI of peritumor edema area can effectively distinguish GL from MTB, and improve the accuracy of early clinical screening, thus providing more reliable life security for patients.
format Online
Article
Text
id pubmed-9486092
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-94860922022-09-21 Efficacy evaluation of contrast-enhanced magnetic resonance imaging in differentiating glioma from metastatic tumor of the brain and exploration of its association with patients’ neurological function Shi, Zhuo Jiang, Jiuming Xie, Lizhi Zhao, Xinming Front Behav Neurosci Neuroscience OBJECTIVE: To determine the efficacy of contrast-enhanced MRI in differentiating glioma (GL) from the metastatic tumor of the brain (MTB) and its association with patients’ neurological function. METHODS: A retrospective analysis was conducted on 49 cases of pathologically confirmed GL and 42 cases of MTB admitted between April 2019 and January 2022. All patients were examined by a set of MRI sequences that included T1WI, T2WI, FLAIR, and DWI. The values of fractional anisotropy (FA), apparent diffusion coefficient (ADC), and operation coefficient (K(trans)) were calculated by taking the tumor parenchyma area, cystic area, and peritumor edema area as the regions of interest (ROIs). And according to the Mini-mental state examination (MMSE) results, the contrast-enhanced MRI with patients’ neurological dysfunction was observed. RESULTS: The clinical symptoms and MRI findings of MTB and GL were basically the same, mainly showing neurological symptoms. The tumor parenchyma area and cystic area were mainly located in the tumor periphery and tumor central area, respectively, while the peritumor edema area was widely distributed, showing an irregular patchy edema zone. Contrast-enhanced scans suggested an obvious enhancement in the tumor parenchymal area, presenting with nodular and annular enhancement, but no enhancement in the tumor cystic and peritumor edema areas. There was no difference between GL and MTB in FA values of tumor cystic area and peritumor edema area (P > 0.05), but the FA value of the parenchyma area of GL was higher (P < 0.05). Besides, GL and MTB showed no difference in ADC and K(trans) values (P > 0.05), while the former presented lower ADC values and higher K(trans) values of the peritumor edema area than the latter (P < 0.05). In patients with GL and MTB, the FA and K(trans) values of all ROIs in those with neurological dysfunction were higher compared with those without neurological dysfunction, while the ADC values were lower (P < 0.05). CONCLUSION: Contrast-enhanced MRI of peritumor edema area can effectively distinguish GL from MTB, and improve the accuracy of early clinical screening, thus providing more reliable life security for patients. Frontiers Media S.A. 2022-09-06 /pmc/articles/PMC9486092/ /pubmed/36147544 http://dx.doi.org/10.3389/fnbeh.2022.957795 Text en Copyright © 2022 Shi, Jiang, Xie and Zhao. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Neuroscience
Shi, Zhuo
Jiang, Jiuming
Xie, Lizhi
Zhao, Xinming
Efficacy evaluation of contrast-enhanced magnetic resonance imaging in differentiating glioma from metastatic tumor of the brain and exploration of its association with patients’ neurological function
title Efficacy evaluation of contrast-enhanced magnetic resonance imaging in differentiating glioma from metastatic tumor of the brain and exploration of its association with patients’ neurological function
title_full Efficacy evaluation of contrast-enhanced magnetic resonance imaging in differentiating glioma from metastatic tumor of the brain and exploration of its association with patients’ neurological function
title_fullStr Efficacy evaluation of contrast-enhanced magnetic resonance imaging in differentiating glioma from metastatic tumor of the brain and exploration of its association with patients’ neurological function
title_full_unstemmed Efficacy evaluation of contrast-enhanced magnetic resonance imaging in differentiating glioma from metastatic tumor of the brain and exploration of its association with patients’ neurological function
title_short Efficacy evaluation of contrast-enhanced magnetic resonance imaging in differentiating glioma from metastatic tumor of the brain and exploration of its association with patients’ neurological function
title_sort efficacy evaluation of contrast-enhanced magnetic resonance imaging in differentiating glioma from metastatic tumor of the brain and exploration of its association with patients’ neurological function
topic Neuroscience
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9486092/
https://www.ncbi.nlm.nih.gov/pubmed/36147544
http://dx.doi.org/10.3389/fnbeh.2022.957795
work_keys_str_mv AT shizhuo efficacyevaluationofcontrastenhancedmagneticresonanceimagingindifferentiatinggliomafrommetastatictumorofthebrainandexplorationofitsassociationwithpatientsneurologicalfunction
AT jiangjiuming efficacyevaluationofcontrastenhancedmagneticresonanceimagingindifferentiatinggliomafrommetastatictumorofthebrainandexplorationofitsassociationwithpatientsneurologicalfunction
AT xielizhi efficacyevaluationofcontrastenhancedmagneticresonanceimagingindifferentiatinggliomafrommetastatictumorofthebrainandexplorationofitsassociationwithpatientsneurologicalfunction
AT zhaoxinming efficacyevaluationofcontrastenhancedmagneticresonanceimagingindifferentiatinggliomafrommetastatictumorofthebrainandexplorationofitsassociationwithpatientsneurologicalfunction